![Naomi Cretcher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Naomi Cretcher
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIOMEA FUSION, INC. | Responsable des Ressources Humaines | 01/02/2021 | - |
Directeur des opérations | 01/07/2020 | 01/02/2021 |
Historique de carrière de Naomi Cretcher
Anciens postes connus de Naomi Cretcher
Sociétés | Poste | Début | Fin |
---|---|---|---|
Kartos Therapeutics, Inc.
![]() Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Operating Officer | 1 |
Human Resources Officer | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOMEA FUSION, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Kartos Therapeutics, Inc.
![]() Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
- Bourse
- Insiders
- Naomi Cretcher
- Expérience